Abstract

Aim: To measure the severity of the disorder with and without Agoraphobia in P.D. patients and determine the relation of comorbid psychological symptoms and conditions in these two groups.

Methods: The study is a cross-sectional observational studydone in a tertiary psychiatry care center from October 2019 to August 2020. The Patients age between (17–54) Y with Panic Disorder (P.D.) were separated into two groups Panic Disorder without Agoraphobia P.D and Panic Disorder with Agoraphobia (PDAG), which were associatedwithalteration in the severity of anxiety by{Panic Disorder Severity Scale (PDSS), the incidence of comorbidity and their effect on the severity of signs and symptoms. All statistical investigateswere carried by SPSS V. 25.0. the statistical test is a p-value of less than 0.05 has been taken to indicate a significant difference.

Results: The present study included (118) patients (95) subjects were panic disorder, and 23 subjects were Panic Agoraphobia disorder. The finding shows that the demographical characteristic of P.D. and PAD. Diagnosis of the two groups based on DSM5 and the Cymbalta was given to the PDA group 12 (20.33%), while Sertraline was given to the P.D. group 11 (18.96%).

Conclusion: The magnitude of signs as calculated on the consistent scale for P.D. (PDSS score 21.3 in P.D. group, PDAG, 13.5; p=0.035), the occurrence of comorbidity (60/100 in P.D. group 83.3 percentage in PDAG group,) were substantially different in both groups. The prevalence of Agoraphobia was relatedtofurther severe disease, the expanded incidence of fear, and additional symptoms of anxiety, comorbid psychological disorders,

Keyworsds: Panic , Agoraphobia,Iraq